{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:02:38Z","timestamp":1794358958219,"version":"4.9.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-036437"],"award-info":[{"award-number":["INV-036437"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gaps in India\u2019s routine dengue surveillance have led to an underestimation of its actual burden and could adversely affect funding for preventive public health measures. In this study, we report the incidence of symptomatic dengue and the associated direct medical costs in a large urban population-based cohort in Vellore, Tamil Nadu.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Surveillance for febrile illnesses was conducted in 30 urban wards in Vellore as part of the Vellore Typhoid Vaccine Impact Trial. Participants seeking healthcare for febrile illnesses called the trial helpline, triggering active surveillance until fever defervescence. Febrile episodes lasting\u2009\u2265\u20093 days were diagnosed as dengue based on either laboratory tests or a physician-assigned diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From May 2023 to January 2025, 74,587 participants aged 1\u201330 years contributed 124,018.4 person-years (PYs) of follow-up. We identified 188 laboratory-confirmed and 107 physician-assigned diagnoses of dengue. From May 2023 to April 2024, the incidence of laboratory-confirmed dengue was 150.3 per 100,000 PYs (95% confidence interval [CI]: 124.4\u2013181.7), and 205.2 per 100,000 PYs (95% CI: 174.4\u2013241.3) for all dengue cases. The median direct medical cost for laboratory-confirmed dengue treated as outpatients was Indian Rupees (INR) 4,357 (interquartile range [IQR]: 2,432\u20137,204), and INR 16,827 (IQR: 9,556\u201326,348) for those who were hospitalised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The incidence of dengue and its associated treatment costs were high in this urban setting. Strengthening routine disease surveillance with enhanced diagnostic testing and systematically collected data from the private sector will provide better estimates of the dengue burden in India and inform policy decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12545-x","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T09:08:00Z","timestamp":1769159280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and healthcare costs of symptomatic dengue in an urban, city-wide cohort in South India"],"prefix":"10.1186","volume":"26","author":[{"given":"Nikhil","family":"Sahai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimi Elizabeth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Miraculine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Anish Selwyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isai","family":"Thamizh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winsley","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baker Ninan","family":"Fenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gowrishankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narmada","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3654-5099","authenticated-orcid":false,"given":"Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"12545_CR1","unstructured":"World Health Organization. Global dengue surveillance. 2005. https:\/\/worldhealthorg.shinyapps.io\/dengue_global\/. Accessed 24 Mar 2025."},{"key":"12545_CR2","unstructured":"National Vector Borne Disease Control Programme (NVBDCP)- Government of India. National vector borne disease control programme annual report 2014\u201315. National Vector Borne Disease Control Programme (NVBDCP)- Government of India. 2015. https:\/\/ncvbdc.mohfw.gov.in\/Doc\/Annual-report-NVBDCP-2014-15.pdf. Accessed 4 Jul 2025."},{"key":"12545_CR3","unstructured":"National Vector Borne Disease Control Programme (NVBDCP)- Government of India. Dengue situation in India. 2025. https:\/\/ncvbdc.mohfw.gov.in\/index4.php?lang=1%26level=0%26linkid=431%26lid=3715. Accessed 4 Jul 2025."},{"key":"12545_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(24)01542-3","volume":"404","author":"The Lancet","year":"2024","unstructured":"The Lancet. Dengue: the threat to health now and in the future. Lancet. 2024;404:311.","journal-title":"Lancet"},{"key":"12545_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/tropicalmed6040180","volume":"6","author":"JO Obi","year":"2021","unstructured":"Obi JO, Guti\u00e9rrez-Barbosa H, Chua JV, Deredge DJ. Current trends and limitations in dengue antiviral research. Trop Med Infect Dis. 2021;6:180.","journal-title":"Trop Med Infect Dis"},{"key":"12545_CR6","doi-asserted-by":"publisher","first-page":"108942","DOI":"10.1016\/j.isci.2024.108942","volume":"27","author":"AA Hoffmann","year":"2024","unstructured":"Hoffmann AA, Ahmad NW, Keong WM, Ling CY, Ahmad NA, Golding N, et al. Introduction of Aedes aegypti mosquitoes carrying wAlbB wolbachia sharply decreases dengue incidence in disease hotspots. iScience. 2024;27:108942.","journal-title":"iScience"},{"key":"12545_CR7","first-page":"203","volume":"99","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. WHO position paper on dengue vaccine- May 2024. Wkly Epidemiol Rec. 2024;99:203\u201324.","journal-title":"Wkly Epidemiol Rec"},{"key":"12545_CR8","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.jvacx.2022.100142","volume":"10","author":"L Mohanty","year":"2022","unstructured":"Mohanty L, Prabhu M, Kumar Mishra A, Purty AJ, Kanungo R, Ghosh G, et al. Safety and immunogenicity of a single dose, live-attenuated \u2018tetravalent dengue vaccine\u2019 in healthy Indian adults; a randomized, double-blind, placebo controlled phase I\/II trial. Vaccin X. 2022;10:100142.","journal-title":"Vaccin X"},{"key":"12545_CR9","doi-asserted-by":"publisher","first-page":"100021","DOI":"10.1016\/j.dcit.2024.100021","volume":"2","author":"S-X Zhang","year":"2024","unstructured":"Zhang S-X, Yang G-B, Zhang R-J, Zheng J-X, Yang J, Lv S, et al. Global, regional, and National burden of dengue, 1990\u20132021: findings from the global burden of disease study 2021. Decoding Infect Transm. 2024;2:100021.","journal-title":"Decoding Infect Transm"},{"key":"12545_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13063-023-07555-y","volume":"24","author":"N Sahai","year":"2023","unstructured":"Sahai N, Arunachalam DK, Morris T, Copas A, Samuel P, Mohan VR, et al. An observer-blinded, cluster randomised trial of a typhoid conjugate vaccine in an urban South Indian cohort. Trials. 2023;24:492.","journal-title":"Trials"},{"key":"12545_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.23-0542","volume":"111","author":"N Gupta","year":"2024","unstructured":"Gupta N, Boodman C, Jouego CG, Van Den Broucke S. Duration of fever in patients with dengue: A systematic review and meta-analysis. Am J Trop Med Hyg. 2024;111:5\u201310.","journal-title":"Am J Trop Med Hyg"},{"key":"12545_CR12","unstructured":"National Commission on Population- Government of India. Census of India 2011- population projections for India and states 2011\u20132036. Ministry of Health and Family Welfare- Government of India. 2020. https:\/\/www.india.gov.in\/population-projections-india-and-states-2011-2036?page=3. Accessed 4 Jul 2025."},{"key":"12545_CR13","volume-title":"Stata statistical software. Release 17","author":"StataCorp","year":"2021","unstructured":"StataCorp. Stata statistical software. Release 17. College Station, TX: StataCorp LLC; 2021."},{"key":"12545_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: elegant graphics for data analysis. Cham: Springer international publishing; 2016."},{"key":"12545_CR15","unstructured":"R Core Team. (2021). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. https:\/\/www.R-project.org\/. Accessed 22 Aug 2025."},{"key":"12545_CR16","volume-title":"Special programme for research and training in tropical diseases. Dengue: guidelines for diagnosis, treatment, prevention and control","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Special programme for research and training in tropical diseases. Dengue: guidelines for diagnosis, treatment, prevention and control. New Edition: WHO; 2009."},{"key":"12545_CR17","unstructured":"National Statistics Office- Government of India. Consumer price index numbers on base 2012\u2009=\u2009100 for rural, urban and combined for the month of April, 2025. Press Information Bureau- Government of India. 2025. https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2128387. Accessed 31 Jul 2025."},{"key":"12545_CR18","unstructured":"European Centre for Disease Prevention and Control. Twelve-month dengue virus disease case notification rate per 100 000 population, April 2024 - March 2025. European Centre for Disease Prevention and Control. 2025. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/twelve-month-dengue-virus-disease-case-notification-rate-100-000-population-april. Accessed 21 May 2025."},{"key":"12545_CR19","doi-asserted-by":"publisher","first-page":"e1065","DOI":"10.1016\/S2214-109X(19)30250-5","volume":"7","author":"MV Murhekar","year":"2019","unstructured":"Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde P, et al. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health. 2019;7:e1065\u201373.","journal-title":"Lancet Glob Health"},{"key":"12545_CR20","unstructured":"Ministry of Health and Family Welfare- Government of India. Press Releases- Union Health Secretary chairs a high-level inter-ministerial meeting to review the dengue situation and preparedness status in 9 states, focusing on the prevention, containment, and management of dengue cases. Press Information Bureau- Government of India. 2024. https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=2040968. Accessed 28 Mar 2025."},{"key":"12545_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/09720634221091011","volume":"24","author":"KM Furtado","year":"2022","unstructured":"Furtado KM, Kar A. Private sector engagement for infectious disease surveillance in mixed health systems: lessons from a model dengue reporting network in India. J Health Manag. 2022;24:583\u201392.","journal-title":"J Health Manag"},{"key":"12545_CR22","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1080\/17441692.2020.1767674","volume":"15","author":"E Pilot","year":"2020","unstructured":"Pilot E, Murthy GVS, Nittas V. Understanding india\u2019s urban dengue surveillance: A qualitative policy analysis of Hyderabad district. Glob Public Health. 2020;15:1702\u201317.","journal-title":"Glob Public Health"},{"key":"12545_CR23","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.ijid.2019.01.010","volume":"84S","author":"D Hariharan","year":"2019","unstructured":"Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: A systematic analysis. Int J Infect Dis. 2019;84S:S68\u201373.","journal-title":"Int J Infect Dis"},{"key":"12545_CR24","doi-asserted-by":"publisher","first-page":"e0006618","DOI":"10.1371\/journal.pntd.0006618","volume":"12","author":"P Ganeshkumar","year":"2018","unstructured":"Ganeshkumar P, Murhekar MV, Poornima V, Saravanakumar V, Sukumaran K, Anandaselvasankar A, et al. Dengue infection in india: A systematic review and meta-analysis. PLOS Negl Trop Dis. 2018;12:e0006618.","journal-title":"PLOS Negl Trop Dis"},{"issue":"Suppl 5","key":"12545_CR25","doi-asserted-by":"publisher","first-page":"S548","DOI":"10.1093\/infdis\/jiab329","volume":"224","author":"M Srinivasan","year":"2021","unstructured":"Srinivasan M, Sindhu KN, Nag A, Karthikeyan AS, Ramasamy RK, Murugesan M, et al. Hospitalization rates and direct medical costs for fever in a pediatric cohort in South India. J Infect Dis. 2021;224(Suppl 5):S548\u201357.","journal-title":"J Infect Dis"},{"key":"12545_CR26","unstructured":"National Statistics Office- Government of India. Household consumption expenditure survey: 2023\u20132024 Fact Sheet. Ministry of Statistics and Programme Implementation- Government of India. 2025. https:\/\/www.mospi.gov.in\/sites\/default\/files\/publication_reports\/HCES%20FactSheet%202023-24.pdf. Accessed 25 Sep 2025."},{"key":"12545_CR27","unstructured":"Ministry of Health and Family Welfare- Government of India. ICMR and Panacea BioTeC initiate the First Dengue vaccine Phase 3 Clinical Trial in India with Indigenous Dengue vaccine, DengiAll. Press Information Bureau- Government of India. 2024. https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=2045090. Accessed 28 Mar 2025."},{"key":"12545_CR28","unstructured":"Das S. India may have dengue vaccine by 2026; Takeda initiates clinical trials. Business Standard. 2024. https:\/\/www.business-standard.com\/health\/india-may-have-dengue-vaccine-by-2026-takeda-initiates-clinical-trials-124072501161_1.html. Accessed 18 Aug 2025."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12545-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:00:37Z","timestamp":1781629237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12545-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12545"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12545-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The original VEVACT study was approved by the Indian Health Ministry Screening Committee (proposal ID 2022\u201316229, dated March 16, 2022) and the Institutional Review Board (IRB) of Christian Medical College, Vellore (IRB minutes number 14247, dated 29\/09\/2021). Written informed consent was obtained from all adult participants and parents or guardians of the child participants, and assent was sought wherever applicable. All research activities conducted as part of the VEVACT study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"370"}}